Key result
Elevated homocysteine drives NET formation to worsen platelet activation and neuronal damage in stroke.
Why the study?
Do homocysteine and its biochemical modifications drive neutrophil extracellular trap formation and exacerbate neuronal damage in ischemic stroke?
Do homocysteine and its biochemical modifications drive neutrophil extracellular trap formation and exacerbate neuronal damage in ischemic stroke?
Answers are grounded in this paper and cite their sources.
Homocysteine and its modifications act as key metabolic regulators of NETosis in stroke, linking NET formation to platelet activation and neuronal damage, presenting potential therapeutic targets.
Excessive production of neutrophil extracellular traps (NETs) contributes to immunothrombosis activation in ischemic stroke pathogenesis. The metabolic and mechanistic regulators of NET formation in relation to platelet activation during ischemic stroke remain poorly understood. In the present study, using multiple animal and clinical models of stroke, we examined the role of homocysteine and its biochemical modifications on NET formation and concomitant neuronal damage, platelet aggregation, motor and gait functions. Phosphoproteomics analysis of neutrophils in response to homocysteine revealed an enrichment of kinases and phosphoproteins associated with thrombosis. Homocysteinylated albumin induced significant NET formation via Erk1/2, Akt, ATM, and PAD4-dependent pathways, independent of reactive oxygen species. Hyperhomocysteinemic mice fed a methionine-rich diet exhibited elevated NETs components (neutrophil elastase, citrullinated histones, cell-free DNA (cfDNA)), platelet activation, neuronal damage, and impaired motor, balance, and learning functions. UCCAO-induced ischemia exacerbated neuronal damage, motor dysfunction, and platelet activation in hyperhomocysteinemic mice, which were reversed by disrupting NETs with N-acetyl cysteine and DNase. In stroke patients, homocysteine, neutrophil elastase, and cfDNA levels were significantly elevated, independent of comorbidities (e.g., hypertension, type 2 diabetes), etiology (TOAST classification), or stroke severity. Additionally, stroke patients generated autoantibodies against homocysteinylated albumin, which positively correlated with neutrophil elastase levels. This study identifies homocysteine and its modifications as key metabolic regulators of NETosis in stroke, linking NETs formation to platelet activation and neuronal damage. These findings highlight potential therapeutic targets for mitigating stroke pathogenesis through the modulation of NETs.
No takes yet. Share an insight, caveat, or question.
Nair et al. (2025) studied Ischemic stroke. Homocysteine was evaluated on Neutrophil extracellular trap (NET) formation, platelet activation, and neuronal damage. Elevated homocysteine levels in stroke patients and hyperhomocysteinemic mice drove neutrophil extracellular trap formation, exacerbating platelet activation and neuronal damage.
Synapse has enriched 10 related papers. Consider them for comparative context: